ADVI Health Attending Meeting on the Mesa 2025

As a proud Gold-level sponsor, ADVI Health’s Marc Samuels, JD, MPH, CEO, and Alicia Silver, MPP, senior director, will be attending this year’s Alliance for Regenerative Medicine’s 2025 Cell & Gene Meeting on the Mesa from October 6-8 in Phoenix, Arizona.

Marc will be presenting the session, “Understanding the Impact of MFN and Tariffs on the Cell and Gene Therapy Sector,” highlighting global pricing policies such as MFN rules and evolving tariff structures, expanding on how they are reshaping the economics of cell and gene therapy and the real-world implications for developers, manufacturers, and investors.

Get in touch to meet with our ADVI experts and learn more about our insights and expertise.

ADVI Team

Marc Samuels, JD, MPH

Chief Executive Officer

Alicia Silver, MPP

Senior Director

Further Resources:

ADVI insights

Insights,

| Tyler Seville, MPA - Senior Manager

The Unintended Consequences of Drug Pricing Policies on Orphan Drug Development

Insights,

| Charles Sewell - Senior Associate

ADVI Analysis: MACPAC October 2024 Meeting